These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 8632906

  • 1. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD.
    Oncogene; 1996 Feb 15; 12(4):839-46. PubMed ID: 8632906
    [Abstract] [Full Text] [Related]

  • 2. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N, Salgia R, Li JL, Pisick E, Sattler M, Griffin JD.
    Leukemia; 1997 Mar 15; 11(3):376-85. PubMed ID: 9067577
    [Abstract] [Full Text] [Related]

  • 3. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK, Langdon WY, Varticovski L.
    Oncogene; 1997 May 08; 14(18):2217-28. PubMed ID: 9174058
    [Abstract] [Full Text] [Related]

  • 4. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.
    Salgia R, Sattler M, Pisick E, Li JL, Griffin JD.
    Exp Hematol; 1996 Feb 08; 24(2):310-3. PubMed ID: 8641358
    [Abstract] [Full Text] [Related]

  • 5. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R, Pisick E, Sattler M, Li JL, Uemura N, Wong WK, Burky SA, Hirai H, Chen LB, Griffin JD.
    J Biol Chem; 1996 Oct 11; 271(41):25198-203. PubMed ID: 8810278
    [Abstract] [Full Text] [Related]

  • 6. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R, Uemura N, Okuda K, Li JL, Pisick E, Sattler M, de Jong R, Druker B, Heisterkamp N, Chen LB.
    J Biol Chem; 1995 Dec 08; 270(49):29145-50. PubMed ID: 7493940
    [Abstract] [Full Text] [Related]

  • 7. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
    Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, Griffin JD.
    J Biol Chem; 1997 Apr 11; 272(15):10248-53. PubMed ID: 9092574
    [Abstract] [Full Text] [Related]

  • 8. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A, Kolibaba K, Oda T, Ohno-Jones S, Heaney C, Druker BJ.
    J Biol Chem; 1997 Jun 27; 272(26):16170-5. PubMed ID: 9195915
    [Abstract] [Full Text] [Related]

  • 9. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R, van Wijk A, Haataja L, Heisterkamp N, Groffen J.
    J Biol Chem; 1997 Dec 19; 272(51):32649-55. PubMed ID: 9405482
    [Abstract] [Full Text] [Related]

  • 10. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
    Andoniou CE, Thien CB, Langdon WY.
    Oncogene; 1996 May 02; 12(9):1981-9. PubMed ID: 8649859
    [Abstract] [Full Text] [Related]

  • 11. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
    Sattler M, Pride YB, Quinnan LR, Verma S, Malouf NA, Husson H, Salgia R, Lipkowitz S, Griffin JD.
    Oncogene; 2002 Feb 21; 21(9):1423-33. PubMed ID: 11857085
    [Abstract] [Full Text] [Related]

  • 12. The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase.
    Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE, Band H.
    J Biol Chem; 1995 Aug 11; 270(32):19141-50. PubMed ID: 7642581
    [Abstract] [Full Text] [Related]

  • 13. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
    Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, Law SF, Golemis EA, Griffin JD.
    J Biol Chem; 1997 May 30; 272(22):14320-6. PubMed ID: 9162067
    [Abstract] [Full Text] [Related]

  • 14. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
    Voss J, Posern G, Hannemann JR, Wiedemann LM, Turhan AG, Poirel H, Bernard OA, Adermann K, Kardinal C, Feller SM.
    Oncogene; 2000 Mar 23; 19(13):1684-90. PubMed ID: 10763825
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY, Xue F, Feng J, Skorski T.
    Exp Hematol; 2005 Oct 23; 33(10):1222-8. PubMed ID: 16219545
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
    Ribon V, Hubbell S, Herrera R, Saltiel AR.
    Mol Cell Biol; 1996 Jan 23; 16(1):45-52. PubMed ID: 8524328
    [Abstract] [Full Text] [Related]

  • 19. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
    Okuda K, Golub TR, Gilliland DG, Griffin JD.
    Oncogene; 1996 Sep 19; 13(6):1147-52. PubMed ID: 8808688
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
    Barber DL, Mason JM, Fukazawa T, Reedquist KA, Druker BJ, Band H, D'Andrea AD.
    Blood; 1997 May 01; 89(9):3166-74. PubMed ID: 9129019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.